Asia
Europe, Middle East, Africa
North America
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.
Net sales for the first quarter amounted to €307 million, up 6.4% at constant exchange rates and scope of consolidation (on a like-for-like basis) versus the first quarter of 2009.
Sales up 6.4% at constant exchange rates and scope of consolidation.
Download the Complete Press Release: